SANA - Sana Biotechnology Inc

SANA - Sana Biotechnology Inc

https://www.sana.com

Hold Momentum: Bearish

Recent News

Powered by Alpha Vantage

Sana Biotechnology to Present at September 2025 Investor Conferences

GlobeNewswire • 2 weeks, 5 days ago • score: 0.06

SEATTLE, Aug. 26, 2025 ( GLOBE NEWSWIRE ) -- Sana Biotechnology, Inc. ( NASDAQ: SANA ) , a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in September.

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares - Sana Biotechnology ( NASDAQ:SANA )

Benzinga • 3 weeks, 4 days ago • score: 0.21

SEATTLE, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Sana Biotechnology, Inc.

Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares

GlobeNewswire • 3 weeks, 4 days ago • score: 0.19

SEATTLE, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Sana Biotechnology, Inc. ( Nasdaq: SANA ) ( "Sana" ) , a company focused on changing the possible for patients through engineered cells, today announced that it has closed the sale of 3,358,208 shares of its common stock at a price to the public of ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

Sana Biotechnology, Inc., a biotechnology company, focuses on the use of modified cells as medicines. The company is headquartered in Seattle, Washington.

52W High

$5.33

52W Low

$1.26

MA Status:

50D: Below 200D: Above

Beta (~1 neutral, <0.9 lower risk)

1.89

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-1.08

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

6.13

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

7.75%

Institutions (25–75% balanced)

78.03%

Shares Outstanding

253,892,000

Float

155,383,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

-1.06

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-1.09%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.1511

Previous

-0.1761

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025